Literature DB >> 3004634

Distinct IgG recognition patterns during progression of subclinical and clinical infection with lymphadenopathy associated virus/human T lymphotropic virus.

J M Lange, R A Coutinho, W J Krone, L F Verdonck, S A Danner, J van der Noordaa, J Goudsmit.   

Abstract

Longitudinal IgG recognition patterns of viral proteins were studied in 15 men who had seroconverted for lymphadenopathy associated virus/human T lymphotropic virus (LAV/HTLV-III). Antibodies to the major viral core protein p24, which is a cleavage product of the gag gene encoded precursor protein pr55, appeared first. These were soon followed by antibodies to pr55 and more gradually by antibodies to the other gag gene encoded cleavage product p18, the env gene encoded transmembrane glycoprotein gp41, the env gene encoded glycoproteins gp65 and gp110, and the putative pol gene product p33. In 13 subjects who remained healthy the reactivity to the different proteins increased or stabilised with time, while in two men who developed acquired immune deficiency syndrome (AIDS) the reactivity, most noticeably to gag encoded proteins, diminished before or at the onset of symptoms.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3004634      PMCID: PMC1339204          DOI: 10.1136/bmj.292.6515.228

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  18 in total

1.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

2.  A dot-immunobinding assay for monoclonal and other antibodies.

Authors:  R Hawkes; E Niday; J Gordon
Journal:  Anal Biochem       Date:  1982-01-01       Impact factor: 3.365

3.  Antibodies reactive with human T-lymphotropic retroviruses (HTLV-III) in the serum of patients with AIDS.

Authors:  M G Sarngadharan; M Popovic; L Bruch; J Schüpbach; R C Gallo
Journal:  Science       Date:  1984-05-04       Impact factor: 47.728

4.  Detection of IgG antibodies to lymphadenopathy-associated virus in patients with AIDS or lymphadenopathy syndrome.

Authors:  F Brun-Vezinet; C Rouzioux; F Barre-Sinoussi; D Klatzmann; A G Saimot; W Rozenbaum; D Christol; J C Gluckmann; L Montagnier; J C Chermann
Journal:  Lancet       Date:  1984-06-09       Impact factor: 79.321

5.  Isolation of new lymphotropic retrovirus from two siblings with haemophilia B, one with AIDS.

Authors:  E Vilmer; F Barre-Sinoussi; C Rouzioux; C Gazengel; F V Brun; C Dauguet; A Fischer; P Manigne; J C Chermann; C Griscelli
Journal:  Lancet       Date:  1984-04-07       Impact factor: 79.321

6.  Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS).

Authors:  F Barré-Sinoussi; J C Chermann; F Rey; M T Nugeyre; S Chamaret; J Gruest; C Dauguet; C Axler-Blin; F Vézinet-Brun; C Rouzioux; W Rozenbaum; L Montagnier
Journal:  Science       Date:  1983-05-20       Impact factor: 47.728

7.  Variation in human T lymphotropic virus III (HTLV-III) antibodies in homosexual men: decline before onset of illness related to acquired immune deficiency syndrome (AIDS).

Authors:  R J Biggar; M Melbye; P Ebbesen; S Alexander; J O Nielsen; P Sarin; V Faber
Journal:  Br Med J (Clin Res Ed)       Date:  1985-10-12

8.  Efficacy of a heat inactivated hepatitis B vaccine in male homosexuals: outcome of a placebo controlled double blind trial.

Authors:  R A Coutinho; N Lelie; P Albrecht-Van Lent; E E Reerink-Brongers; L Stoutjesdijk; P Dees; J Nivard; J Huisman; H W Reesink
Journal:  Br Med J (Clin Res Ed)       Date:  1983-04-23

9.  Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS.

Authors:  R C Gallo; S Z Salahuddin; M Popovic; G M Shearer; M Kaplan; B F Haynes; T J Palker; R Redfield; J Oleske; B Safai
Journal:  Science       Date:  1984-05-04       Impact factor: 47.728

10.  Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS.

Authors:  M Popovic; M G Sarngadharan; E Read; R C Gallo
Journal:  Science       Date:  1984-05-04       Impact factor: 47.728

View more
  47 in total

Review 1.  Clinical, virological and immunological features of primary HIV-1 infection.

Authors:  M D de Jong; H J Hulsebosch; J M Lange
Journal:  Genitourin Med       Date:  1991-10

2.  Recovery of antibody production after HIV infection in 'common' variable hypogammaglobulinaemia.

Authors:  A D Webster; A Lever; G Spickett; R Beattie; M North; R Thorpe
Journal:  Clin Exp Immunol       Date:  1989-09       Impact factor: 4.330

3.  Densitometric analysis of Western blot (immunoblot) assays for human immunodeficiency virus antibodies and correlation with clinical status.

Authors:  G Schmidt; K Amiraian; H Frey; R W Stevens; D S Berns
Journal:  J Clin Microbiol       Date:  1987-10       Impact factor: 5.948

4.  HIV infection and STD in drug addicted prostitutes in Amsterdam: potential for heterosexual HIV transmission.

Authors:  J A van den Hoek; H J van Haastrecht; B Scheeringa-Troost; J Goudsmit; R A Coutinho
Journal:  Genitourin Med       Date:  1989-06

5.  Serological diagnosis of HIV infection: incidence, outcome and significance of partial reactions found in western blot analysis.

Authors:  J P Lantin; I Graf; P C Frei
Journal:  Clin Exp Immunol       Date:  1989-06       Impact factor: 4.330

Review 6.  More reliable diagnosis of infection with human immunodeficiency virus type 1 (HIV-1) by detection of antibody IgGs to pol and gag proteins of HIV-1 and p24 antigen of HIV-1 in urine, saliva, and/or serum with highly sensitive and specific enzyme immunoassay (immune complex transfer enzyme immunoassay): a review.

Authors:  S Hashida; K Hashinaka; S Ishikawa; E Ishikawa
Journal:  J Clin Lab Anal       Date:  1997       Impact factor: 2.352

7.  Biological significance of the antibody response to HIV antigens expressed on the cell surface.

Authors:  J Goudsmit; K Ljunggren; L Smit; M Jondal; E M Fenyö; M Jonda
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

8.  Patterns of antigenaemia and antibody response in patients infected with human immunodeficiency virus (HIV) according to clinical state.

Authors:  M C Re; G Furlini; M La Placa
Journal:  J Clin Pathol       Date:  1989-03       Impact factor: 3.411

9.  Intra-blood-brain barrier synthesis of human immunodeficiency virus antigen and antibody in humans and chimpanzees.

Authors:  J Goudsmit; L G Epstein; D A Paul; H J van der Helm; G J Dawson; D M Asher; R Yanagihara; A V Wolff; C J Gibbs; D C Gajdusek
Journal:  Proc Natl Acad Sci U S A       Date:  1987-06       Impact factor: 11.205

10.  Enzyme immunoassay using a novel recombinant polypeptide to detect human immunodeficiency virus env antibody.

Authors:  R M Thorn; G A Beltz; C H Hung; B F Fallis; S Winkle; K L Cheng; D J Marciani
Journal:  J Clin Microbiol       Date:  1987-07       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.